A comparative study of different imaging modalities for successful percutaneous left atrial appendage closure
Danny Hf Chow, Gintautas Bieliauskas, Fadi J Sawaya, Oscar Millan-Iturbe, Klaus F Kofoed, Lars Søndergaard, Ole De Backer, Danny Hf Chow, Gintautas Bieliauskas, Fadi J Sawaya, Oscar Millan-Iturbe, Klaus F Kofoed, Lars Søndergaard, Ole De Backer
Abstract
Objectives: Accurate sizing of the left atrial appendage (LAA) is essential when performing percutaneous LAA closure. This study aimed to compare different LAA imaging modalities and sizing methods in order to obtain successful LAA closure.
Background: Percutaneous LAA closure is an increasingly used treatment strategy to prevent stroke in patients with atrial fibrillation. LAA sizing has typically been done by 2D-transoesophageal echocardiography (TEE).
Methods: Patients who had a preprocedural TEE and preprocedural and postprocedural multislice CT (MSCT) were identified. Preprocedural measurements of LAA ostia and landing zones by 2D-TEE, MSCT and angiography were collected and analysed for those patients with successful LAA closure - i.e. with no contrast leakage at 3-month follow-up MSCT.
Results: The study population (n=67) had a mean CHA2DS2-VASc score of 3.0 and HAS-BLED score of 2.7. Fifty-eight patients (87%) were identified to have successful LAA closure. Based on MSCT, 48 LAA sizings (83%) resulted in a correct LAA closure device size selection, whereas with 2D-TEE sizing, only 33 measurements (57%) would have resulted in a correct device size selection (p<0.01). Using adapted Bland-Altman method, MSCT-based perimeter-derived mean diameter was shown to be the best parameter to guide LAA device size selection for ‘closed-end’ devices (Amulet, WatchmanFLX), whereas the maximal diameter was the best parameter for the ‘open-end’ Watchman device.
Conclusions: Preprocedural MSCT-based LAA closure device size selection proves to be a more accurate method than conventional 2D-TEE-based sizing. Depending on the LAA closure device design, perimeter-derived mean diameter or maximal diameter could be the better sizing method.
Keywords: ATRIAL FIBRILLATION; DEVICE CLOSURE; STROKE.
Conflict of interest statement
Competing interests: None declared.
Figures
References
- Kirchhof P, Benussi S, Kotecha D, et al. . 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J 2016;37:2893–962.10.1093/eurheartj/ehw210
- Reddy VY, Sievert H, Halperin J, et al. . Percutaneous left atrial appendage closure vs warfarin for atrial fibrillation: a randomized clinical trial. JAMA 2014;312:1988–98.10.1001/jama.2014.15192
- Onalan O, Crystal E. Left atrial appendage exclusion for stroke prevention in patients with nonrheumatic atrial fibrillation. Stroke 2007;38:624–30.10.1161/01.STR.0000250166.06949.95
- De Backer O, Arnous S, Ihlemann N, et al. . Percutaneous left atrial appendage occlusion for stroke prevention in atrial fibrillation: an update. Open Heart 2014;1:e000020.10.1136/openhrt-2013-000020
- Saw J, Lempereur M. Percutaneous left atrial appendage closure: procedural techniques and outcomes. JACC Cardiovasc Interv 2014;7:1205–20.10.1016/j.jcin.2014.05.026
- Kempfert J, Van Linden A, Lehmkuhl L, et al. . Aortic annulus sizing: echocardiographic versus computed tomography derived measurements in comparison with direct surgical sizing. Eur J Cardiothorac Surg 2012;42:627–33.10.1093/ejcts/ezs064
- Kerut EK. Anatomy of the left atrial appendage. Echocardiography 2008;25:669–73.10.1111/j.1540-8175.2008.00637.x
- Shah SJ, Bardo DM, Sugeng L, et al. . Real-time three-dimensional transesophageal echocardiography of the left atrial appendage: initial experience in the clinical setting. J Am Soc Echocardiogr 2008;21:1362–8.10.1016/j.echo.2008.09.024
- Wunderlich NC, Beigel R, Swaans MJ, et al. . Percutaneous interventions for left atrial appendage exclusion: options, assessment, and imaging using 2D and 3D echocardiography. JACC Cardiovasc Imaging 2015;8:472–88.10.1016/j.jcmg.2015.02.002
- Viles-Gonzalez JF, Kar S, Douglas P, et al. . The clinical impact of incomplete left atrial appendage closure with the Watchman Device in patients with atrial fibrillation: a PROTECT AF (Percutaneous closure of the left Atrial Appendage Versus Warfarin therapy for Prevention of Stroke in Patients with Atrial Fibrillation) substudy. J Am Coll Cardiol 2012;59:923–9.10.1016/j.jacc.2011.11.028
- Bieliauskas G, Otton J, Chow DHF, et al. . Use of 3-Dimensional Models to Optimize Pre-Procedural Planning of Percutaneous Left Atrial Appendage Closure. JACC Cardiovasc Interv 2017;10:1067–70.10.1016/j.jcin.2017.02.027
Source: PubMed